Automate Your Wheel Strategy on OMCL
With Tiblio's Option Bot, you can configure your own wheel strategy including OMCL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OMCL
- Rev/Share 25.435
- Book/Share 26.3671
- PB 1.4074
- Debt/Equity 0.1596
- CurrentRatio 1.4447
- ROIC 0.0067
- MktCap 1718743638.0
- FreeCF/Share 2.4073
- PFCF 15.4192
- PE 86.2621
- Debt/Assets 0.1
- DivYield 0
- ROE 0.016
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | OMCL | Wells Fargo | Equal Weight | Overweight | -- | $35 | May 14, 2025 |
News
Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.53%: Here's is How to Trade
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 34.5% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Buy 5 Stocks With Extensive Robotics Application for the Rest of 2025
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Five robotics-driven stocks - PATH, EMR, TRMB, OMCL and LECO - are set to gain traction heading into late 2025.
Read More
Omnicell, Inc. (OMCL) Q3 2025 Earnings Call Transcript
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Omnicell, Inc. ( OMCL ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Kathleen Nemeth - Senior Vice President of Investor Relations Randall Lipps - Founder, Executive Chairman, President & CEO H. Radford - Executive VP & CFO Conference Call Participants Jessica Tassan - Piper Sandler & Co., Research Division Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division David Larsen - BTIG, LLC, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Eugene Mannheimer - …
Read More
Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 43.7% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Negative
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Are Investors Undervaluing Omnicell (OMCL) Right Now?
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value investors?
Read More
Is Omnicell (OMCL) Stock Undervalued Right Now?
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Reasons to Add Omnicell Stock to Your Portfolio Right Now
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
OMCL's expanding SaaS portfolio, overseas growth plans, and solid balance sheet position it for sustained momentum despite rising competition.
Read More
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Is Omnicell (OMCL) a Great Value Stock Right Now?
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Published: September 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Wall Street Analysts Think Omnicell (OMCL) Could Surge 39.36%: Read This Before Placing a Bet
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Earnings Estimates Rising for Omnicell (OMCL): Will It Gain?
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.18%: Here's is How to Trade
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 34.2% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Omnicell (OMCL) points to a 44.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
Omnicell Q2 Earnings: Market Ignoring The Segments
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Positive
Omnicell's service business is rapidly growing, now 22% of revenue, outpacing industry trends and supporting long-term upside. My updated DCF analysis yields a price target of $57.46, representing 93% upside, with Wall Street consensus trailing behind. The primary risk is the pace of transition from product to service revenue, but a strong backlog mitigates margin and cash flow concerns.
Read More
OMCL vs. DOCS: Which Stock Is the Better Value Option?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Doximity (DOCS). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Negative
OMCL stays on investors' radar due to its strong 2025 growth targets with automation and tech services, but faces margin risks from macro and competitive headwinds.
Read More
Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue?
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?
Read More
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program
Published: May 22, 2025 by: Business Wire
Sentiment: Neutral
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program.
Read More
Omnicell's New Perioperative Clinic Setting Products May Boost Stock
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
OMCL unveils new offerings for the perioperative and clinic setting.
Read More
Omnicell: Facing New Headwinds
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Negative
Omnicell, Inc., a small cap medical technology solutions provider, posted its Q1 results Tuesday. Both top and the bottom-line results beat the consensus. However, thanks to some new headlines and reduced forward guidance, OMCL shares sold off 15% in trading yesterday. A buying opportunity? An analysis around Omnicell follows in the paragraphs below.
Read More
Omnicell, Inc. (OMCL) Q1 2025 Earnings Conference Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - SVP, IR Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta - EVP and CFO Nnamdi Njoku - COO Conference Call Participants Jessica Datson - Piper Sandler Gene Mannheimer - Freedom Capital Markets Allen Lutz - Bank of America Bill Sutherland - Benchmark Stan Berenshteyn - Wells Fargo Matt Hewitt - Craig-Hallum Capital David Larsen - BTIG Operator Good morning, my name is Carly and I will be your conference operator today. At this time, I would like to …
Read More
Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.03 per share a year ago.
Read More
Omnicell Announces First Quarter 2025 Results
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces First Quarter 2025 Results.
Read More
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Omnicell (OMCL) is a Strong Value Stock
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
About Omnicell, Inc. (OMCL)
- IPO Date 2001-08-09
- Website https://www.omnicell.com
- Industry Medical - Healthcare Information Services
- CEO Randall A. Lipps
- Employees 3620